2014
DOI: 10.1172/jci73093
|View full text |Cite
|
Sign up to set email alerts
|

EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis

Abstract: BACKGROUND: Oncogenic EGFR-Akt signaling is aberrantly activated in human glioblastomas. Discoid, CUC and LCCL domain containing protein 2 (DCBLD2, also known as CLCP1 and ESDN) is a neuropilin-like membrane protein that is up-regulated in vascular injury and metastatic lung cancers. However, the role of DCBLD2 in cancer is unclear. METHODS: We examined the expression of DCBLD2 in TCGA and other data bases of clinical glioma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
91
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 80 publications
(92 citation statements)
references
References 49 publications
(114 reference statements)
1
91
0
Order By: Relevance
“…To further determine whether KAT6A is critical for glioma tumorigenesis, we employed an orthotopic GBM model as we previously described (26). U87 GBM cells transduced with shKAT6A-1, shKAT6A-2 or shControl were separately implanted intracranially to generate orthotopic xenografts in immunocompromised mice.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…To further determine whether KAT6A is critical for glioma tumorigenesis, we employed an orthotopic GBM model as we previously described (26). U87 GBM cells transduced with shKAT6A-1, shKAT6A-2 or shControl were separately implanted intracranially to generate orthotopic xenografts in immunocompromised mice.…”
Section: Resultsmentioning
confidence: 99%
“…Since AKT activation is important for histone acetyltransferase function (27-30) and glioma cell proliferation (26), we determined the effect of KAT6A knockdown on phosphorylation of AKT (p-AKT) in U87 and LN229 GBM cells. As shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…U87 neurosphere cells were seeded into 96-well round bottom plates and treated with vehicle (DMSO) alone or rapamycin, an inhibitor of the mammalian target of rapamycin complex 1 (mTORC1), or erlotinib, an epidermal growth factor receptor (EGFR) inhibitor that was previously shown to attenuate neurosphere size (12). To investigate whether the data obtained by our neurosphere assay correlate with cell viability, duplicate experiments were done in parallel for simultaneous analysis by the neurosphere assay and a water-soluble tetrazolium salt-1 (WST-1) proliferation assay as described previously (13).…”
Section: Methods Summarymentioning
confidence: 99%
“…It is conceivable that ESDN intracellular domain can similarly be involved in its interactions with IR and adaptor proteins, APS and Grb10. Previous work has implicated ESDN in regulation of VEGF, PDGF, and epidermal growth factor (EGF) signal transduction (9,13,28). Our new findings on ESDN regulation of insulin signaling suggest that ESDN might regulate the biological effects of other growth factors.…”
Section: Discussionmentioning
confidence: 57%